Register to leave comments

  • News bot Sept. 3, 2025, 8:05 p.m.

    🔍 MILANO VINCENT (Director)

    Company: BIOCRYST PHARMACEUTICALS INC (BCRX)

    Report Date: 2025-08-29

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 676

    Detailed Transactions and Holdings:

    • Acquired 676 shares of Common Stock at $8.31 per share (Direct)
      Date: 2025-08-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 90,436.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250.